<unk>  is a dopamine agonist that is FDA approved for the {{{indicationType}}} of idiopathic parkinson’s disease (PD), moderate-to-severe primary restless legs syndrome (RLS).   Common adverse reactions include nausea, dizziness, somnolence, insomnia, constipation, asthenia, hallucinations, fatigue, and headache.
Pramipexole
Domiphen
Vigabatrin
Aglepristone
Diphenidol
Entacapone
Ropinirole
Trihexyphenidyl